Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Melanoma 1656Skin Neoplasms 355Lymphoma, T-Cell, Cutaneous 322Carcinoma, Basal Cell 241Mycosis Fungoides 227Sezary Syndrome 209Breast Neoplasms 196Leukemia, Lymphocytic, Chronic, B-Cell 193Lymphoma, Non-Hodgkin 192Lymphoma, Follicular 187Precursor Cell Lymphoblastic Leukemia-Lymphoma 183Lymphoma, Large B-Cell, Diffuse 183Lymphoma, B-Cell, Marginal Zone 182Lymphoma, Mantle-Cell 181Hodgkin Disease 175Lymphoma 174Burkitt Lymphoma 173Uveal Melanoma 170Lymphoma, Large-Cell, Immunoblastic 168Multiple Myeloma 159Keratosis, Actinic 146Neoplasms 142Leukemia, Myeloid, Acute 134Neoplasm Metastasis 125Lymphoma, Large-Cell, Anaplastic 125Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 123Lung Neoplasms 120Immunoblastic Lymphadenopathy 115Leukemia, Myeloid, Accelerated Phase 113Leukemia, Myeloid, Chronic-Phase 112

Interventions

Gels 1Bexarotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Parapsoriasis × Dermatologic × Clear all
NCT00322296 2013-04-16

Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis

Fox Chase Cancer Center

Phase 2 Terminated
8 enrolled
DermatologicLymphoid

Mycosis Fungoides, Parapsoriasis, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡